Standex (SXI) director granted 639 restricted shares; now 14,424
Standex International (SXI) reported an insider equity award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Standex International (SXI) reported an insider equity award. Director Alan J. Glass acquired 639 shares of common stock on 10/21/2025 via a restricted stock grant under the Company’s 2018 Omnibus Incentive Plan. The award carries a $0 price, reflecting a grant rather than an open‑market purchase, and vests three years after the date of grant.
Following this transaction, the reporting person beneficially owned 14,424 shares, held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 639 | $0.00 | $0.00 |
Footnotes (1)
- F1. Grant of Restricted Stock pursuant to the Company's 2018 Omnibus Incentive Plan that vests three years after the date of grant.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did SXI disclose in this Form 4?
Who is the reporting person in the SXI Form 4?
What type of equity was awarded to the SXI director?
What is the vesting schedule for the SXI restricted stock grant?
Is the ownership direct or indirect after the SXI grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.